MX2016009355A - Inhibidores de aril lactama cinasa. - Google Patents
Inhibidores de aril lactama cinasa.Info
- Publication number
- MX2016009355A MX2016009355A MX2016009355A MX2016009355A MX2016009355A MX 2016009355 A MX2016009355 A MX 2016009355A MX 2016009355 A MX2016009355 A MX 2016009355A MX 2016009355 A MX2016009355 A MX 2016009355A MX 2016009355 A MX2016009355 A MX 2016009355A
- Authority
- MX
- Mexico
- Prior art keywords
- kinase inhibitors
- aryl lactam
- lactam kinase
- aryl
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invención se refiere a compuestos los cuales pueden inhibir a AKK1 (adaptador asociado a cinasa 1), composiciones que comprenden tales compuestos, y métodos para inhibir a AAK1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2014/013539 WO2015116060A1 (en) | 2014-01-29 | 2014-01-29 | Aryl lactam kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016009355A true MX2016009355A (es) | 2016-10-13 |
Family
ID=50073525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016009355A MX2016009355A (es) | 2014-01-29 | 2014-01-29 | Inhibidores de aril lactama cinasa. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20160333006A1 (es) |
EP (1) | EP3099300B1 (es) |
JP (1) | JP6276865B2 (es) |
CN (1) | CN106132414A (es) |
CA (1) | CA2937529A1 (es) |
EA (1) | EA028587B1 (es) |
ES (1) | ES2693771T3 (es) |
MX (1) | MX2016009355A (es) |
WO (1) | WO2015116060A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2958924B1 (en) | 2013-02-22 | 2016-12-28 | Bristol-Myers Squibb Company | 5h-chromeno[3,4-c]pyridines as inhibitors of adaptor associated kinase 1 (aak1) |
WO2015006100A1 (en) | 2013-07-08 | 2015-01-15 | Bristol-Myers Squibb Company | Aryl amide kinase inhibitors |
CN105979950A (zh) | 2013-10-11 | 2016-09-28 | 百时美施贵宝公司 | 吡咯并三嗪激酶抑制剂 |
SG11201608195QA (en) | 2014-04-02 | 2016-10-28 | Bristol Myers Squibb Co | Biaryl kinase inhibitors |
EP3292124B1 (en) | 2015-04-10 | 2019-05-22 | Bristol-Myers Squibb Company | 6h-isochromeno[3,4-c]pyridines and benzo[c][1,7]naphthyridin-6-(5h)-ones as adaptor associated kinase 1 (aak1) inhibitors |
US10544120B2 (en) | 2015-10-01 | 2020-01-28 | Bristol-Myers Squibb Company | Biaryl kinase inhibitors |
WO2017059080A1 (en) | 2015-10-01 | 2017-04-06 | Bristol-Myers Squibb Company | Biaryl kinase inhibitors |
CN111825702A (zh) * | 2019-04-22 | 2020-10-27 | 成都科岭源医药技术有限公司 | 一种氮杂*并吲唑类衍生物及其制备方法和用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPS137402A0 (en) * | 2002-03-26 | 2002-05-09 | Fujisawa Pharmaceutical Co., Ltd. | Novel tricyclic compounds |
US20090060852A1 (en) * | 2007-07-27 | 2009-03-05 | Jack Dejovin | Compounds, Formulations and Methods for Reducing Skin Wrinkles, Creasing and Sagging |
US9968574B2 (en) * | 2009-05-15 | 2018-05-15 | The University Of Kentucky Research Foundation | Treatment of MCI and Alzheimer's disease |
AU2010353287A1 (en) * | 2010-05-13 | 2012-11-29 | The University Of Kentucky Research Foundation | Treatment of MCI and Alzheimer's disease |
US8703953B2 (en) * | 2012-03-09 | 2014-04-22 | Bristol-Myers Squibb Company | Aryl ether-base kinase inhibitors |
US8901305B2 (en) * | 2012-07-31 | 2014-12-02 | Bristol-Myers Squibb Company | Aryl lactam kinase inhibitors |
JP6243539B2 (ja) * | 2013-09-11 | 2017-12-06 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | アリールエーテルをベースとするキナーゼ阻害剤 |
-
2014
- 2014-01-29 US US15/111,416 patent/US20160333006A1/en not_active Abandoned
- 2014-01-29 CA CA2937529A patent/CA2937529A1/en not_active Abandoned
- 2014-01-29 EP EP14704047.1A patent/EP3099300B1/en active Active
- 2014-01-29 MX MX2016009355A patent/MX2016009355A/es unknown
- 2014-01-29 ES ES14704047.1T patent/ES2693771T3/es active Active
- 2014-01-29 JP JP2016549022A patent/JP6276865B2/ja active Active
- 2014-01-29 EA EA201691549A patent/EA028587B1/ru not_active IP Right Cessation
- 2014-01-29 CN CN201480077532.3A patent/CN106132414A/zh active Pending
- 2014-01-29 WO PCT/US2014/013539 patent/WO2015116060A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP2017504630A (ja) | 2017-02-09 |
EA028587B1 (ru) | 2017-12-29 |
CA2937529A1 (en) | 2015-08-06 |
EP3099300B1 (en) | 2018-09-05 |
CN106132414A (zh) | 2016-11-16 |
EA201691549A1 (ru) | 2017-02-28 |
EP3099300A1 (en) | 2016-12-07 |
WO2015116060A1 (en) | 2015-08-06 |
JP6276865B2 (ja) | 2018-02-07 |
ES2693771T3 (es) | 2018-12-13 |
US20160333006A1 (en) | 2016-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016012829A (es) | Inhibidores de biaril cinasa. | |
PH12018501151A1 (en) | Tank-binding kinase inhibitor compounds | |
TW201613886A (en) | 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones | |
MX2020005213A (es) | Inhibidores de proteina cinasa 2 activada por proteina cinasa activada por mitogeno (mk2) y sus usos. | |
MX2018009773A (es) | Heteroarilos inhibidores de peptidilarginina desiminasa 4 (pad4). | |
MX2016015862A (es) | Compuestos inhibidores de la cinasa de union a tank. | |
MX2016009352A (es) | Inhibidores de quinasa a base de quinolina. | |
MX2016009355A (es) | Inhibidores de aril lactama cinasa. | |
MX2015008999A (es) | Inhibidores mk2 y usos de los mismos. | |
NZ725917A (en) | Novel polymerase-i inhibitors, uses and methods for making them | |
MX2018006632A (es) | Inhibidores biciclicos de peptidilarginina deiminasa 4 (pad4). | |
MX2017003930A (es) | Derivados de aminotriazina utiles como compuestos inhibidores de la cinasa de union a tank. | |
MX2015000980A (es) | Inhibidores de aril lactama cinasa. | |
MX2016015565A (es) | Ciertos inhibidores de la proteina quinasa. | |
PH12020500072A1 (en) | Heterocyclic inhibitors of atr kinase | |
MX2016002924A (es) | Inhibidores de cinasa a base de eter arilico. | |
EA201491647A1 (ru) | Основанные на арилэфирах ингибиторы киназ | |
MX2018006700A (es) | Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4). | |
MX2022010755A (es) | Inhibidores de quinasa y usos de los mismos. | |
MX2020003439A (es) | Compuestos biciclicos para usarse como inhibidores de cinasa de la proteina 1 de interaccion con receptores (rip1). | |
PH12016500347A1 (en) | Triazolopyridine compounds, compositions and methods of use thereof | |
MX2020003706A (es) | Aminoimidazopiridazinas como inhibidores de cinasa. | |
TN2018000057A1 (en) | Compounds useful for inhibiting ror-gamma-t. | |
MA39824A (fr) | Composés azole amido-substitués | |
TW201612165A (en) | Preparation method for aromatic heterocyclic compound used as selective jak3 and/or jak1 kinase inhibitor and application of aromatic heterocyclic compound |